Periostin	NN
promotes	VBZ
fibrosis	NN
and	CC
predicts	VBZ
progression	NN
in	IN
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
progressive	JJ
fibrotic	JJ
lung	NN
disease	NN
without	IN
effective	JJ
therapeutics	NNS
.	.

Periostin	NNP
has	VBZ
been	VBN
reported	VBN
to	TO
be	VB
elevated	JJ
in	IN
IPF	NN
patients	NNS
relative	JJ
to	TO
controls	NNS
,	,
but	CC
its	PRP$
sources	NNS
and	CC
mechanisms	NNS
of	IN
action	NN
remain	VBP
unclear	JJ
.	.

We	PRP
confirm	VBP
excess	JJ
periostin	NN
in	IN
lungs	NNS
of	IN
IPF	NN
patients	NNS
and	CC
show	VBP
that	IN
IPF	NN
fibroblasts	NNS
produce	VBP
periostin	NN
.	.

Blood	NN
was	VBD
obtained	VBN
from	IN
54	CD
IPF	NN
patients	NNS
(	(
all	DT
but	CC
1	CD
with	IN
48	CD
wk	NN
of	IN
follow-up	NN
)	)
.	.

We	PRP
show	VBP
that	IN
periostin	NN
levels	NNS
predict	VBP
clinical	JJ
progression	NN
at	IN
48	CD
wk	NN
(	(
hazard	NN
ratio	NN
=	JJ
1.47	CD
,	,
95	CD
%	NN
confidence	NN
interval	NN
=	JJ
1.03-2.10	CD
,	,
P	NN
<	JJR
0.05	CD
)	)
.	.

Monocytes	NNS
and	CC
fibrocytes	NNS
are	VBP
sources	NNS
of	IN
periostin	NN
in	IN
circulation	NN
in	IN
IPF	NN
patients	NNS
.	.

Previous	JJ
studies	NNS
suggest	VBP
that	IN
periostin	NN
may	MD
regulate	VB
the	DT
inflammatory	JJ
phase	NN
of	IN
bleomycin-induced	JJ
lung	NN
injury	NN
,	,
but	CC
periostin	JJ
effects	NNS
during	IN
the	DT
fibroproliferative	JJ
phase	NN
of	IN
the	DT
disease	NN
are	VBP
unknown	JJ
.	.

Wild-type	JJ
and	CC
periostin-deficient	JJ
(	(
periostin	NN
(	(
-	:
/	:
-	:
)	)
)	)
mice	NNS
were	VBD
anesthetized	JJ
and	CC
challenged	VBN
with	IN
bleomycin	NN
.	.

Wild-type	JJ
mice	NNS
were	VBD
injected	VBN
with	IN
bleomycin	NN
and	CC
then	RB
treated	VBN
with	IN
OC-20	NN
Ab	NN
(	(
which	WDT
blocks	VBZ
periostin	NN
and	CC
integrin	NN
interactions	NNS
)	)
or	CC
control	NN
Ab	NNS
during	IN
the	DT
fibroproliferative	JJ
phase	NN
of	IN
disease	NN
,	,
and	CC
fibrosis	NN
and	CC
survival	NN
were	VBD
assessed	VBN
.	.

Periostin	NN
expression	NN
was	VBD
upregulated	VBN
quickly	RB
after	IN
treatment	NN
with	IN
bleomycin	NN
and	CC
remained	VBD
elevated	JJ
.	.

Periostin	NN
(	(
-	:
/	:
-	:
)	)
mice	NNS
were	VBD
protected	VBN
from	IN
bleomycin-induced	JJ
fibrosis	NN
.	.

Instillation	NN
of	IN
OC-20	NN
during	IN
the	DT
fibroproliferative	JJ
phase	NN
improved	VBD
survival	NN
and	CC
limited	JJ
collagen	NN
deposition	NN
.	.

Chimeric	JJ
mouse	NN
studies	NNS
suggest	VBP
that	IN
hematopoietic	JJ
and	CC
structural	JJ
sources	NNS
of	IN
periostin	NN
contribute	VBP
to	TO
lung	NN
fibrogenesis	NN
.	.

Periostin	NNP
was	VBD
upregulated	VBN
by	IN
transforming-growth-factor-b	NN
in	IN
lung	NN
mesenchymal	JJ
cells	NNS
,	,
and	CC
periostin	NN
promoted	VBD
extracellular	JJ
matrix	NN
deposition	NN
,	,
mesenchymal	JJ
cell	NN
proliferation	NN
,	,
and	CC
wound	NN
closure	NN
.	.

Thus	RB
periostin	NN
plays	VBZ
a	DT
vital	JJ
role	NN
in	IN
late	JJ
stages	NNS
of	IN
pulmonary	JJ
fibrosis	NN
and	CC
is	VBZ
a	DT
potential	JJ
biomarker	NN
for	IN
disease	NN
progression	NN
and	CC
a	DT
target	NN
for	IN
therapeutic	JJ
intervention	NN
.	.

